Doctor profile · Federal record
Dr. Christopher Antolini, MD
Rheumatology Physician (CMS: Rheumatology) · Denver, CO
- NPI 1750302592
- Accepts Medicare
- MIPS 91.2 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
(303) 394-2828
fax (303) 320-0242
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- September 6, 2023
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Colorado #0046724
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750302592. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
24,225
Distinct HCPCS
10
Medicare allowed
$762,345
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,525 | 20 | $42 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 5,750 | 11 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 5,400 | 62 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,830 | 15 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 381 | 193 | $129 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 286 | 70 | $136 | |
J7050 |
Infusion, normal saline solution, 250 cc | 193 | 53 | $1 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 176 | 80 | $75 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 150 | 18 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 139 | 59 | $8 |
In context: peer comparison
Among 19 peers in Denver Rheumatology Physician, average services per provider: 2,043. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$348
Transactions
16
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $93.80 | |
| Abbvie INC. | 2 | $54.20 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $53.79 | |
| Amgen INC. | 2 | $46.39 | |
| Novartis Pharmaceuticals Corporation | 2 | $46.10 | |
| Kiniksa Pharmaceuticals International, Plc | 1 | $19.19 | |
| Radius Health, INC. | 1 | $17.97 | |
| Genentech USA, INC. | 1 | $16.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,278
Patients
347
Total drug cost
$38,746
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 251 | 94 | $2,578 |
| Methotrexate (Methotrexate Sodium) | Brand | 194 | 44 | $8,538 |
| Hydroxychloroquine Sulfate | Generic | 163 | 50 | $13,299 |
| Tramadol Hcl | Generic | 133 | 41 | $2,218 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 74 | 21 | $2,064 |
| Gabapentin | Generic | 68 | 18 | $937 |
| Celecoxib | Generic | 65 | 25 | $3,411 |
| Allopurinol | Generic | 60 | 15 | $1,310 |
| Meloxicam | Generic | 50 | 13 | $407 |
| Folic Acid | Generic | 47 | 14 | $320 |
Hospital affiliations
Frequently asked questions
What is Dr. Christopher Antolini's medical specialty?
Dr. Christopher Antolini practices Rheumatology Physician in Denver, CO.
Where does Dr. Christopher Antolini practice?
Dr. Christopher Antolini practices at 7111 E Lowry Blvd Ste 200, Denver, CO 802307360. Office phone: 3033942828.
What is Dr. Christopher Antolini's NPI?
Dr. Christopher Antolini's National Provider Identifier (NPI) is 1750302592, issued by NPPES.
Does Dr. Christopher Antolini accept Medicare assignment?
Yes. Dr. Christopher Antolini accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Antolini commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.